Unpacking the two newest FDA-approved drugs for Alzheimer’s disease
Monoclonal Antibodies: From COVID-19 to Alzheimer’s
Why are Alzheimer’s disease drugs failing?
Targeting an important protein in the pathway of Alzheimer’s disease is not proving itself to be the cure-all people hoped for
PennNeuroKnow 